Potassium Chloride in Lactated Ringers and Dextrose is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Dextrose Monohydrate; Sodium Chloride; Sodium Lactate; Potassium Chloride; Calcium Chloride.
Product ID | 0338-0811_21521bf9-77d1-4851-8dc1-22a075138c3f |
NDC | 0338-0811 |
Product Type | Human Prescription Drug |
Proprietary Name | Potassium Chloride in Lactated Ringers and Dextrose |
Generic Name | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Potassium Chloride, Calcium Chloride |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1985-04-05 |
Marketing Category | NDA / NDA |
Application Number | NDA019367 |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM LACTATE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE |
Active Ingredient Strength | 5 g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |